Product Information
RIPA-56 is an experimental drug that belongs to a class of acyltransferases. It has shown to be effective in preventing the development of tubulointerstitial injury in the experimental model and prevents cytosolic calcium overload by inhibiting phospholipase A2. RIPA-56 also inhibits apoptosis pathways and has been shown to be effective against autoimmune diseases, such as hepatitis B virus-induced hepatic steatosis and toxic epidermal necrolysis. RIPA-56 interacts with toll-like receptor 4 (TLR4) which is a protein that recognizes bacterial lipopolysaccharides on the surface of cells and activates immune response.
Chemical properties
Technical inquiry about: 3D-GDD37021 RIPA-56
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
